Learning objective:         

After watching this broadcast, participants should be able to:

• Discuss and explain new data on prostate cancer from APCCC 2021
• Discuss how these new data will affect and be integrated into daily clinical practice

Faculty:

• Kurt Miller (Germany)
• Heather Payne (UK)
• Alberto Bossi (France)
• Robert Jones (UK)
...

In the last 10 years, important advancements in the treatment and management of patients with advanced prostate cancer were implemented in daily clinical practice. It is now the right time to reflect on what was achieved and to discuss the focus and development of management and new treatment options for men with prostate cancer in the years to come.

This ...

Video recording by the congress organisers of the Janssen Symposium from the ESMO Congress 2021 that took place on 18 September.

Learning objective:         

After watching this broadcast, participants should be able to:

• Reflect on novel management paradigms for patients with EGFR+ NSCLC, who are resistant to EGFR targeted therapies
• Evaluate new and emerging diagnostic ...

Learning objective:         

After watching this broadcast, participants should be able to:

• Discuss and explain new data in bladder cancer from September 2021
• Integrate the new data into the current disease landscape and discuss how these will affect clinical practice

Faculty:

• Alison Birtle (UK)
• Ignacio Duran (Spain)
• Maria De Santis (Germany)
• Fred Witjes ...

Learning objective:         

After watching this broadcast, participants should be able to:

• Evaluate novel data in molecular testing for EGFR+ NSCLC
• Describe recent advances in the management of EGFR+ NSCLC and implications for the care of patients in clinical practice

Faculty:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)
• Reinhard Büttner (Germany)
• Sanjay Popat ...

Learning objective:         

After watching this broadcast, participants should be able to:

• Understand advances in therapeutic options in mHSPC and their impact on clinical practice
• Re-evaluate current clinical decision making and define best practice approaches to individualised care for patients with mHSPC

Scientific Committee: